Humacyte, Inc. Balance Sheet
HUMA|1 years of annual SEC 10-K data (FY2025-FY2025)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity. All figures from audited SEC 10-K filings.
Humacyte, Inc. had $116M in total assets with negative shareholders' equity of $53M as of FY2025. Total debt was $35M against $50M in cash, resulting in a $15M net cash position.
Based on SEC 10-K filings.
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -2.88 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 |
|---|---|
| Cash & Equivalents | $50.5M |
| Accounts Receivable | $441.0K |
| Inventory | $13.6M |
| Current Assets | $67.8M |
| PP&E (Net) | $18.5M |
| Total Assets | $116.4M |
| Current Liabilities | $18.4M |
| Total Debt | $35.4M |
| Shareholders' Equity | -$52.7M |